IS7310A - 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar - Google Patents

3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar

Info

Publication number
IS7310A
IS7310A IS7310A IS7310A IS7310A IS 7310 A IS7310 A IS 7310A IS 7310 A IS7310 A IS 7310A IS 7310 A IS7310 A IS 7310A IS 7310 A IS7310 A IS 7310A
Authority
IS
Iceland
Prior art keywords
tafia
imidazolyl
inhibit
alkoxypropanoic
acids
Prior art date
Application number
IS7310A
Other languages
English (en)
Icelandic (is)
Inventor
Moira Norfor Allerton Charlotte
John Bull David
Edward Bunnage Mark
Sandwich
John Maguire Robert
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0201389A external-priority patent/GB0201389D0/en
Priority claimed from GB0202027A external-priority patent/GB0202027D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7310A publication Critical patent/IS7310A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7310A 2002-01-22 2004-06-14 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar IS7310A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0201389A GB0201389D0 (en) 2002-01-22 2002-01-22 3-(imidazolyl)-2-alkoxypropanoic acids
GB0202027A GB0202027D0 (en) 2002-01-29 2002-01-29 3-(imidazolyl)-2-alkoxypropanoic acids
PCT/IB2003/000060 WO2003061652A1 (en) 2002-01-22 2003-01-10 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors

Publications (1)

Publication Number Publication Date
IS7310A true IS7310A (is) 2004-06-14

Family

ID=27614792

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7310A IS7310A (is) 2002-01-22 2004-06-14 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar

Country Status (24)

Country Link
EP (1) EP1467731A1 (es)
JP (1) JP2005520811A (es)
KR (1) KR20040077775A (es)
CN (1) CN1620291A (es)
AP (1) AP2004003084A0 (es)
AR (1) AR038197A1 (es)
BR (1) BR0307016A (es)
CA (1) CA2472238A1 (es)
EA (1) EA200400716A1 (es)
EC (1) ECSP045200A (es)
HR (1) HRP20040659A2 (es)
IL (1) IL162677A0 (es)
IS (1) IS7310A (es)
MA (1) MA27167A1 (es)
MX (1) MXPA04006573A (es)
NO (1) NO20043457L (es)
OA (1) OA12756A (es)
PA (1) PA8563501A1 (es)
PE (1) PE20030929A1 (es)
PL (1) PL371487A1 (es)
TN (1) TNSN04121A1 (es)
TW (1) TW200302094A (es)
UY (1) UY27615A1 (es)
WO (1) WO2003061652A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051384A1 (en) * 2003-11-25 2005-06-09 Pfizer Limited Stabilised pharmaceutical compositions
JP2008536923A (ja) * 2005-04-18 2008-09-11 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 心筋の再灌流の増強およびpciの容易化のためのtafi阻害剤の使用
WO2010050525A1 (ja) 2008-10-29 2010-05-06 大正製薬株式会社 TAFIa阻害活性を有する化合物
US8987242B2 (en) 2008-12-05 2015-03-24 Merck Sharp & Dohme Corp. Morpholinone compounds as factor IXA inhibitors
JP2012511008A (ja) * 2008-12-05 2012-05-17 持田製薬株式会社 IXa因子阻害薬としてのモルホリノン化合物
BR112012023412A2 (pt) 2010-03-18 2018-05-08 Daiichi Sankyo Company, Limited composto, drogra farmacêutica, inibidor de tafia, promotor de fibrinólise, droga preventiva ou terapêutica, composição farmacêutica, e, uso de um composto.
EP2548871B1 (en) * 2010-03-18 2017-07-19 Daiichi Sankyo Company, Limited Cycloalkyl-substituted imidazole derivative
KR20160018557A (ko) 2013-06-10 2016-02-17 사노피 TAFIa의 저해제로서의 마크로사이클릭 우레아 유도체, 이의 제법 및 의약품으로서의 이의 용도
US20190117624A1 (en) 2016-03-29 2019-04-25 Daiichi Sankyo Company, Limited Therapeutic agent for inflammatory bowel diseases
MY202326A (en) 2017-09-14 2024-04-24 Daiichi Sankyo Co Ltd Compound having cyclic structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
ATE447557T1 (de) * 2000-08-17 2009-11-15 Pfizer Ltd Substitutuierte imidazole als tafia inhibitoren

Also Published As

Publication number Publication date
AR038197A1 (es) 2005-01-05
AP2004003084A0 (en) 2004-09-30
CN1620291A (zh) 2005-05-25
UY27615A1 (es) 2003-08-29
IL162677A0 (en) 2005-11-20
ECSP045200A (es) 2004-08-27
PE20030929A1 (es) 2003-11-05
OA12756A (en) 2006-07-03
BR0307016A (pt) 2004-11-03
TNSN04121A1 (en) 2006-06-01
CA2472238A1 (en) 2003-07-31
PA8563501A1 (es) 2004-08-31
EP1467731A1 (en) 2004-10-20
PL371487A1 (en) 2005-06-13
JP2005520811A (ja) 2005-07-14
WO2003061652A1 (en) 2003-07-31
NO20043457L (no) 2004-08-19
MA27167A1 (fr) 2005-01-03
TW200302094A (en) 2003-08-01
KR20040077775A (ko) 2004-09-06
EA200400716A1 (ru) 2004-12-30
MXPA04006573A (es) 2004-10-04
HRP20040659A2 (en) 2004-10-31
WO2003061652A8 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
EP1736711A4 (en) HUMIDITY CONTROL
MA28630B1 (fr) Inhibiteurs d'iap
DE50309032D1 (de) Fungizide wirkstoffkombinationen
DE60321264D1 (de) Antriebsstranglagerung
NO20055742D0 (no) Gjenget forbindelse for stalror
ATE392813T1 (de) Fungizide wirkstoffkombination
DK1358165T3 (da) Imidazolderivater
DK1311488T3 (da) Substituerede imidazoler som tafia-inhibitorer
ITMI20042462A1 (it) Memoria ausiliare
EP1511179A4 (en) ADAPTIVE CONTROLLER
IS7310A (is) 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar
EP1739371A4 (en) HUMIDITY CONTROL
FI5430U1 (fi) Laatikko
EP1739370A4 (en) HUMIDITY CONTROL
ITBO20040325A1 (it) Dispositivo per l'avvitamento di tappi su corrispondenti articoli
FR2842503B1 (fr) Banderoleuse
DE602004002369D1 (de) Sicherungsmutter
ZA200405344B (en) 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors.
DE10393292D2 (de) Holzmantel
GB0202027D0 (en) 3-(imidazolyl)-2-alkoxypropanoic acids
NO20033080D0 (no) Reguleringssele
DE60230770D1 (de) Verbesserte Speicheranordnung
FI20045287L (fi) Kuivatusviira
GB0201911D0 (en) 3-(Imidazolyl)-2-Aminopropanoic acids
GB0201387D0 (en) 3-(imidazolyl)-2-aminopropanoic acids